PSPergentino José Cunha Souza

Pergentino José Cunha Souza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pergentino José Cunha Souza has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Gisele Zapata-Sudo

    Programa de Pós-Graduação em Cardiologia, Instituto do Coração Edson Saad, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-913, RJ, Brazil

    2 shared publications
  • Roberto Soares de Moura

    Rio de Janeiro State University, 28130, Pharmacology, Rio de Janeiro, Brazil ;

    2 shared publications
  • Roberto Takashi Sudo

    Department of Anesthesiology, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, USA; Institute of Biomedical Sciences, Drug Development Program, Federal University of Rio de Janeiro, Brazil

    2 shared publications
  • Angela de Castro Resende

    Department of Pharmacology and Psychobiology, Roberto Alcantara Gomes Biology Institute (IBRAG), Rio de Janeiro State University (UERJ), Rio de Janeiro 20551-030, RJ, Brazil

    1 shared publication
  • Antonio Palumbo

    Laboratório de Interações Celulares, Instituto de Ciências Biomédicas, Programa de Pesquisa em Biologia Celular e do Desenvolvimento, Universidade Federal do Rio de Janeiro, Prédio do Centro de Ciências da Saúde—Cidade Universitária, Ilha do Fundão, Rua César Pernetta, 1766 (LS.3.01), Rio de Janeiro 21941-902, Brazil

    1 shared publication
  • Carlos A. L. Barros

    Universidade Federal do Para, Belem, Brasil

    1 shared publication

Latest Publications

  • Open Access

    Euterpe oleracea extract inhibits tumorigenesis effect of the chemical carcinogen DMBA in breast experimental cancer

    by Jéssica Alessandra-Perini, Jamila Alessandra Perini, Karina Cristina Rodrigues-Baptista, Roberto Soares de Moura, Antonio Palumbo Junior, Thiago Alves Dos Santos, Pergentino José Cunha Souza, Luiz Eurico Nasciutti, Daniel Escorsim Machado

    Among the processes involved in the breast tumor microenvironment, angiogenesis and inflammation play a central role, and the main factors of these processes are the vascular endothelial growth factor (VEGF), cyclooxygenase 2 (COX-2) and macrophages. Recently, the extract of Euterpe oleracea (açaí), a fruit that is widely found in the Amazon region, already showed antitumorigenic effects in vitro in human breast cancer cell lines. The present study aimed to investigate the effect of açaí on breast cancer using a chemically DMBA (7,12-dimethylbenzanthracene) experimental model. One day after initiation of treatment with açaí, mammary carcinogenesis was induced in female Wistar rats using a subcutaneous injection of 25 mg/kg of DMBA in the mammary gland. Forty rats were randomized into two groups: treated with 200 mg/kg of either açaí extract or vehicle, via gastric tube for 16 consecutive weeks. After treatment, the tumor was collected for macroscopic, histological and immunohistochemical (VEGF, vascular endothelial growth factor receptor 2 -VEGFR-2, COX-2 and matrix metalloproteinase -MMP-9) analyses; peritoneal fluid was subjected to flow cytometry (F4–80/MAC-2+) and ELISA immunoassay (VEGF, prostaglandin E2 -PGE2 and interleukin-10 -IL-10). Heart, liver and kidney samples were collected for histological analysis. After 16 weeks of induction, the mammary carcinoma was confirmed by macroscopic and histological evaluation. Survival analysis indicates that açaí increased the survival (P = .0002, long-rank test) and reduced the deaths number (P = .0036, Chi-square test). Açaí treatment decreased the number of inflammatory cells and macrophage positive cells (Mac-2 + F4–80+), as well as promoting a reduction in immunostaining of VEGF, VEGFR-2 and COX-2. The açaí group also exhibited lower concentrations of PGE2, VEGF and IL-10 compared to the control. The histopathological results of the liver and kidneys showed protective effect of açaí, since in the control group, there was an increase in fibrosis, atypical cells and hemorrhagic microenvironment. The results of this study demonstrated the antiangiogenic and anti-inflammatory potential of açaí, like due to the decreases of the number of activated macrophages, resulting in the inhibition of DMBA carcinogenicity in breast cancer.


  • Open Access

    Antinociceptive effects of hydroalcoholic extract from Euterpe oleracea Mart. (Açaí) in a rodent model of acute and neuropathic pain

    by Roberto T. Sudo, Miguel L. Neto, Carlos E.S. Monteiro, Rachel V. Amaral, Ângela C. Resende, Pergentino J.C. Souza, Gisele Zapata-Sudo, Roberto S. Moura

    Plants rich in flavonoids, such as açaí (Euterpe oleraceae Mart.), can induce antinociception in experimental animals. Here, we tested an extract obtained from the stones of açaí fruits (açaí stone extract, ASE), a native plant from the Amazon region of Brazil, in models of acute/inflammatory and chronic pain. Antinociceptive effects of ASE were evaluated in the hot plate, formalin, acetic acid writhing, carrageenan, and neuropathic pain models, as well as in thermal hyperalgesia and mechanical allodynia models induced by spinal nerve ligation. Antinociceptive activities were modulated by the administration of cholinergic, adrenergic, opioid, and L-arginine-NO antagonists. Oral administration of ASE (30, 100, or 300 mg.kg−1) dose-dependently reduced nociceptive responses to acute/inflammatory pain in mice, including thermal hyperalgesia, acetic acid-induced writhing, and carrageenan-induced thermal hyperalgesia. Moreover, ASE reduced the neurogenic and inflammatory phases after intraplantar injection of formalin in mice. The antinociceptive effect of ASE (100 mg · kg−1) in a hot plate protocol, was inhibited by pre-treatment with naloxone (1 mg · kg−1), atropine (2 mg · kg−1), yohimbine (5 mg · kg−1), or L-NAME (30 mg · kg−1). Furthermore, ASE prevented chronic pain in a rat spinal nerve ligation model, including thermal hyperalgesia and mechanical allodynia. ASE showed significant antinociceptive effect via a multifactorial mechanism of action, indicating that the extract may be useful in the development of new analgesic drugs.


  • Open Access

    Oral treatment with Euterpe oleracea Mart. (açaí) extract improves cardiac dysfunction and exercise intolerance in rats subjected to myocardial infarction

    by Gisele Zapata-Sudo, Jaqueline S da Silva, Sharlene L Pereira, Pergentino Jc Souza, Roberto S de Moura, Roberto Takashi Sudo

    This study was designed to evaluate the cardioprotective effects of Euterpe oleracea Mart., popularly known as “açaí”, on rats subjected to myocardial infarction (MI).


  • Open Access

    Avaliação toxicológica do óleo essencial de Piper aduncum L.

    by Pergentino J. C. Sousa, Carlos A. L. Barros, José Carlos S. Rocha, Denisléia S. Lira, Gisele M. Monteiro, José Guilherme S. Maia


  • Variability in Essential‐Oil Composition of Piper marginatum sensu lato

    by Eloisa Helena A. Andrade, Léa Maria M. Carreira, Milton Helio L. da Silva, João Domingos da Silva, Cleber N. Bastos, Pergentino José C. Sousa, Elsie F. Guimarães, José Guilherme S. Maia

    This paper contains data on the chemical composition of the essential oils of 22 leaf samples of Piper marginatum Jacq. collected in different areas and ecosystems of the brazilian Amazon, as well as an overview of the available literature. The species presents a large synonymy based on their different leaf characteristics and distinct scents where some of them smell like anise or very close compounds. By GC, GC/MS, and cluster analysis, we identified seven chemotypes for the leaf oils. The main components found in chemotype I were safrole (1) and 3,4‐(methylenedioxy)propiophenone (2). The chemotype II was dominated by 3,4‐(methylenedioxy)propiophenone (2) and p‐mentha‐1(7),8‐diene (10). The major compounds identified in chemotype III were 3,4‐(methylenedioxy)propiophenone (2), myristicin (3), (E)‐β‐ocimene (11), and γ‐terpinene (12). In the chemotype IV, the principal constituents were β‐caryophyllene (13), α‐copaene (14), and 3,4‐(methylenedioxy)propiophenone (2). The chemotype V was dominated by (E)‐isoosmorhizole (6), (E)‐anethole (8), and isoosmorhizole (7). The main compounds found in the chemotype VI were 2‐methoxy‐4,5‐(methylenedioxy)propiophenone (4), methoxy‐4,5‐(methylenedioxy)propiophenone isomer 5, and (E)‐isoosmorhizole (6). The major constituents in chemotype VII were β‐caryophyllene (13), bicyclogermacrene (15), and (E)‐asarone (9).